Annual CFI
$732.00 K
+$732.00 K+100.00%
31 December 2023
Summary:
Titan Pharmaceuticals annual cash flow from investing activities is currently $732.00 thousand, with the most recent change of +$732.00 thousand (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$1.27 million (+235.56%). TTNP annual CFI is now -97.61% below its all-time high of $30.68 million, reached on 31 December 2002.TTNP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 June 2024
Summary:
Titan Pharmaceuticals quarterly cash flow from investing activities is not available.TTNP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 June 2024
Summary:
Titan Pharmaceuticals TTM cash flow from investing activities is not available.TTNP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +100.0% | - | - |
3 y3 years | +235.6% | - | - |
5 y5 years | +276.0% | - | - |
TTNP Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +235.6% | ||||
5 y | 5 years | at high | +235.6% | ||||
alltime | all time | -97.6% | +100.8% |
Titan Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $732.00 K(>+9900.0%) | $504.00 K(+121.1%) | $732.00 K(+221.1%) |
Sept 2023 | - | $228.00 K(>+9900.0%) | $228.00 K(>+9900.0%) |
Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
Sept 2022 | - | $0.00(-100.0%) | -$5000.00(-78.3%) |
Dec 2021 | -$23.00 K(-95.7%) | -$5000.00(<-9900.0%) | -$23.00 K(-14.8%) |
Sept 2021 | - | $0.00(-100.0%) | -$27.00 K(-94.3%) |
June 2021 | - | -$18.00 K(+100.0%) | -$471.00 K(-12.8%) |
Dec 2020 | -$540.00 K(+110.9%) | -$9000.00(-98.0%) | -$540.00 K(-16.0%) |
Sept 2020 | - | -$444.00 K(+678.9%) | -$643.00 K(+147.3%) |
June 2020 | - | -$57.00 K(+90.0%) | -$260.00 K(+7.4%) |
Mar 2020 | - | -$30.00 K(-73.2%) | -$242.00 K(-5.5%) |
Dec 2019 | -$256.00 K(-38.5%) | -$112.00 K(+83.6%) | -$256.00 K(-47.6%) |
Sept 2019 | - | -$61.00 K(+56.4%) | -$489.00 K(+9.6%) |
June 2019 | - | -$39.00 K(-11.4%) | -$446.00 K(+10.9%) |
Mar 2019 | - | -$44.00 K(-87.2%) | -$402.00 K(-3.4%) |
Dec 2018 | -$416.00 K(+137.7%) | -$345.00 K(+1816.7%) | -$416.00 K(+357.1%) |
Sept 2018 | - | -$18.00 K(-460.0%) | -$91.00 K(-55.0%) |
June 2018 | - | $5000.00(-108.6%) | -$202.00 K(-2.4%) |
Mar 2018 | - | -$58.00 K(+190.0%) | -$207.00 K(+18.3%) |
Dec 2017 | -$175.00 K(+2.3%) | -$20.00 K(-84.5%) | -$175.00 K(-23.9%) |
Sept 2017 | - | -$129.00 K(<-9900.0%) | -$230.00 K(+54.4%) |
June 2017 | - | $0.00(-100.0%) | -$149.00 K(+6.4%) |
Mar 2017 | - | -$26.00 K(-65.3%) | -$140.00 K(-18.1%) |
Dec 2016 | -$171.00 K(+28.6%) | -$75.00 K(+56.3%) | -$171.00 K(-1.2%) |
Sept 2016 | - | -$48.00 K(-633.3%) | -$173.00 K(+0.6%) |
June 2016 | - | $9000.00(-115.8%) | -$172.00 K(-6.0%) |
Mar 2016 | - | -$57.00 K(-26.0%) | -$183.00 K(+37.6%) |
Dec 2015 | -$133.00 K(+638.9%) | -$77.00 K(+63.8%) | -$133.00 K(+137.5%) |
Sept 2015 | - | -$47.00 K(+2250.0%) | -$56.00 K(+229.4%) |
June 2015 | - | -$2000.00(-71.4%) | -$17.00 K(-26.1%) |
Mar 2015 | - | -$7000.00(<-9900.0%) | -$23.00 K(+27.8%) |
Dec 2014 | -$18.00 K(-94.3%) | $0.00(-100.0%) | -$18.00 K(-53.8%) |
Sept 2014 | - | -$8000.00(0.0%) | -$39.00 K(+30.0%) |
June 2014 | - | -$8000.00(+300.0%) | -$30.00 K(-78.6%) |
Mar 2014 | - | -$2000.00(-90.5%) | -$140.00 K(-56.0%) |
Dec 2013 | -$318.00 K(-72.4%) | -$21.00 K(-2200.0%) | -$318.00 K(-3.3%) |
Sept 2013 | - | $1000.00(-100.8%) | -$329.00 K(-28.9%) |
June 2013 | - | -$118.00 K(-34.4%) | -$463.00 K(-43.0%) |
Mar 2013 | - | -$180.00 K(+462.5%) | -$812.00 K(-29.6%) |
Dec 2012 | -$1.15 M(+393.2%) | -$32.00 K(-75.9%) | -$1.15 M(-11.2%) |
Sept 2012 | - | -$133.00 K(-71.5%) | -$1.30 M(+11.4%) |
June 2012 | - | -$467.00 K(-10.5%) | -$1.17 M(+54.4%) |
Mar 2012 | - | -$522.00 K(+193.3%) | -$756.00 K(+223.1%) |
Dec 2011 | -$234.00 K(+735.7%) | -$178.00 K(<-9900.0%) | -$234.00 K(+265.6%) |
Sept 2011 | - | $0.00(-100.0%) | -$64.00 K(-9.9%) |
June 2011 | - | -$56.00 K(<-9900.0%) | -$71.00 K(+195.8%) |
Mar 2011 | - | $0.00(-100.0%) | -$24.00 K(-14.3%) |
Dec 2010 | -$28.00 K(-1500.0%) | -$8000.00(+14.3%) | -$28.00 K(+47.4%) |
Sept 2010 | - | -$7000.00(-22.2%) | -$19.00 K(+58.3%) |
June 2010 | - | -$9000.00(+125.0%) | -$12.00 K(0.0%) |
Mar 2010 | - | -$4000.00(-500.0%) | -$12.00 K(-700.0%) |
Dec 2009 | $2000.00 | $1000.00(>+9900.0%) | $2000.00(+100.0%) |
Sept 2009 | - | $0.00(-100.0%) | $1000.00(-98.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2009 | - | -$9000.00(-190.0%) | $86.00 K(-25.9%) |
Mar 2009 | - | $10.00 K(-88.2%) | $116.00 K(-99.1%) |
Sept 2008 | - | $85.00 K(+304.8%) | $12.63 M(-13.2%) |
June 2008 | - | $21.00 K(-99.5%) | $14.54 M(+63.0%) |
Mar 2008 | - | $4.31 M(-47.4%) | $8.92 M(<-9900.0%) |
Dec 2007 | -$19.00 K(-100.5%) | $8.21 M(+310.2%) | -$19.00 K(-99.5%) |
Sept 2007 | - | $2.00 M(-135.7%) | -$4.17 M(+171.3%) |
June 2007 | - | -$5.60 M(+21.0%) | -$1.54 M(+0.1%) |
Mar 2007 | - | -$4.63 M(-214.2%) | -$1.54 M(-137.7%) |
Dec 2006 | $4.08 M(-81.9%) | $4.05 M(-12.6%) | $4.08 M(+6.8%) |
Sept 2006 | - | $4.64 M(-182.8%) | $3.82 M(-38.2%) |
June 2006 | - | -$5.60 M(-665.6%) | $6.18 M(-64.9%) |
Mar 2006 | - | $990.00 K(-73.9%) | $17.62 M(-21.8%) |
Dec 2005 | $22.53 M(+182.5%) | $3.79 M(-45.8%) | $22.53 M(-9.8%) |
Sept 2005 | - | $7.00 M(+19.8%) | $24.97 M(+5.2%) |
June 2005 | - | $5.84 M(-1.1%) | $23.73 M(+242.1%) |
Mar 2005 | - | $5.90 M(-5.2%) | $6.94 M(-13.1%) |
Dec 2004 | $7.98 M(-69.3%) | $6.23 M(+8.3%) | $7.98 M(-2.2%) |
Sept 2004 | - | $5.75 M(-152.5%) | $8.15 M(-389.5%) |
June 2004 | - | -$10.95 M(-257.7%) | -$2.82 M(-111.5%) |
Mar 2004 | - | $6.94 M(+8.4%) | $24.51 M(-5.7%) |
Dec 2003 | $26.00 M(-15.2%) | $6.41 M(-222.9%) | $26.00 M(-6.5%) |
Sept 2003 | - | -$5.21 M(-131.8%) | $27.81 M(-32.7%) |
June 2003 | - | $16.37 M(+94.1%) | $41.31 M(+27.1%) |
Mar 2003 | - | $8.44 M(+2.7%) | $32.52 M(+6.0%) |
Dec 2002 | $30.68 M(-1894.0%) | $8.22 M(-0.8%) | $30.68 M(+24.6%) |
Sept 2002 | - | $8.29 M(+9.4%) | $24.63 M(+51.6%) |
June 2002 | - | $7.58 M(+14.8%) | $16.25 M(+44.9%) |
Mar 2002 | - | $6.60 M(+204.0%) | $11.22 M(-755.9%) |
Dec 2001 | -$1.71 M(-98.2%) | $2.17 M(-2361.5%) | -$1.71 M(-93.7%) |
Sept 2001 | - | -$96.00 K(-103.8%) | -$27.27 M(+12.8%) |
June 2001 | - | $2.54 M(-140.2%) | -$24.17 M(-4.8%) |
Mar 2001 | - | -$6.33 M(-72.9%) | -$25.40 M(-73.8%) |
Dec 2000 | -$96.91 M(>+9900.0%) | -$23.38 M(-879.2%) | -$96.91 M(+31.6%) |
Sept 2000 | - | $3.00 M(+128.7%) | -$73.62 M(-4.0%) |
June 2000 | - | $1.31 M(-101.7%) | -$76.72 M(-1.6%) |
Mar 2000 | - | -$77.83 M(>+9900.0%) | -$77.94 M(>+9900.0%) |
Dec 1999 | -$200.00 K(-200.0%) | -$100.00 K(0.0%) | -$200.00 K(-200.0%) |
Sept 1999 | - | -$100.00 K(-200.0%) | $200.00 K(0.0%) |
June 1999 | - | $100.00 K(-200.0%) | $200.00 K(+100.0%) |
Mar 1999 | - | -$100.00 K(-133.3%) | $100.00 K(-50.0%) |
Dec 1998 | $200.00 K(-98.4%) | $300.00 K(-400.0%) | $200.00 K(-77.8%) |
Sept 1998 | - | -$100.00 K(<-9900.0%) | $900.00 K(-10.0%) |
June 1998 | - | $0.00(0.0%) | $1.00 M(-79.6%) |
Mar 1998 | - | $0.00(-100.0%) | $4.90 M(-60.5%) |
Dec 1997 | $12.40 M(-193.2%) | $1.00 M(>+9900.0%) | $12.40 M(-18.4%) |
Sept 1997 | - | $0.00(-100.0%) | $15.20 M(+223.4%) |
June 1997 | - | $3.90 M(-48.0%) | $4.70 M(+51.6%) |
Mar 1997 | - | $7.50 M(+97.4%) | $3.10 M(-123.3%) |
Dec 1996 | -$13.30 M(<-9900.0%) | $3.80 M(-136.2%) | -$13.30 M(-22.2%) |
Sept 1996 | - | -$10.50 M(-556.5%) | -$17.10 M(+159.1%) |
June 1996 | - | $2.30 M(-125.8%) | -$6.60 M(-25.8%) |
Mar 1996 | - | -$8.90 M | -$8.90 M |
Dec 1995 | $0.00 | - | - |
FAQ
- What is Titan Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual CFI year-on-year change?
- What is the all time high quarterly CFI for Titan Pharmaceuticals?
- What is the all time high TTM CFI for Titan Pharmaceuticals?
What is Titan Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of TTNP is $732.00 K
What is the all time high annual CFI for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual cash flow from investing activities is $30.68 M
What is Titan Pharmaceuticals annual CFI year-on-year change?
Over the past year, TTNP annual cash flow from investing activities has changed by +$732.00 K (+100.00%)
What is the all time high quarterly CFI for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly cash flow from investing activities is $16.37 M
What is the all time high TTM CFI for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM cash flow from investing activities is $41.31 M